The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-β

Virology

Volumn 303, Issue 1, 2002, Pages 33-46

  Poole, Emma ^a   He, Biao ^b,d   Lamb, Robert A ^b   Randall, Richard E ^c   Goodbourn, Stephen ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN V;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIMIAN VIRUS;

PARAMYXOVIRIDAE; SIMIAE; SIMIAN PARAINFLUENZA VIRUS 5;

EID: 0036920154     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1737     Document Type: Article

References (76)

1. Abraham, N., Stojdl, D. F., Duncan, P. I., Methot, N., Ishii, T., Dube, M., Vanderhyden, B. C., Atkins, H. L., Gray, D. A., McBurney, M. W., Koromilas, A. E., Brown, E. G., Sonenberg, N., and Bell, J. C. (1999). Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR. J. Biol. Chem. 274, 5953-5962.
2. Andrejeva, J., Young, D. F., Goodbourn, S., and Randall, R. E. (2002). Degradation of STAT1 and STAT2 by the V proteins of SV5 and hPIV2 respectively: Consequences for virus replication in the presence of type I and type II interferon. J. Virol. 76, 2159-2167.
3. Baron, M. D., and Barrett, T. (2000). Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J. Virol. 74, 2603-2611.
4. Biron, C. A., and Sen, G. C. (2001). Interferons and other cytokines. In "Fields Virology" (B. Fields, D. Knipe, and P. Howley, Eds.), 4th ed., pp. 321-349. Lippincott, Williams, and Wilkins, Philadelphia.
5. Chatziandreou, N., Young, D. F., Andrejeva, J., Goodbourn, S., and Randall, R. E. (2002). Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: A model for virus persistence. Virology 293, 234-242.
6. Choppin, P. W. (1964). Multiplication of a myxovirus (SV5) with minimal cytopathic effects and without interference. Virology 23, 224-233.
7. Chu, W. M., Ostertag, D., Li, Z. W., Chang, L., Chen, Y., Hu, Y., Williams, B., Perrault, J., and Karin, M. (1999). JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11, 721-731.
8. Curran, J., Boeck, R., and Kolakofsky, D. (1991). The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J. 10, 3079-3085.
9. Delenda, C., Hausmann, S., Garcin, D., and Kolakofsky, D. (1997). Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology 228, 55-62.
10. Delenda, C., Taylor, G., Hausmann, S., Garcin, D., and Kolakofsky, D. (1998). Sendai viruses with altered P, V, and W protein expression. Virology 242, 327-337.
11. Didcock, L. J., Young, D. F., Goodbourn, S., and Randall, R. E. (1999a). Sendai virus and Simian virus 5 block activation of interferon-responsive genes: Importance for virus pathogenesis. J. Virol. 73, 3125-3133.
12. Didcock, L., Young, D. F., Goodbourn, S., and Randall, R. E. (1999b). The V protein of simian virus 5 inhibits interferon signaling by targetting STAT1 for proteasome-mediated degradation. J. Virol. 73, 9928-9933.
13. Du, W., and Maniatis, T. (1992). An ATF/CREB binding site protein is required for virus induction of the human interferon-β gene. Proc. Natl. Acad. Sci. USA 89, 2150-2154.
14. Du, W., Thanos, D., and Maniatis, T. (1993). Mechanism of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74, 887-898.
15. Ellis, M. J. C., and Goodbourn, S. (1994). NF-κB-independent activation of β-interferon expression in mouse F9 embryonal carcinoma cells. Nucleic Acids Res. 22, 4489-4496.
16. Garcin, D., Latorre, P., and Kolakofsky, D. (1999). Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73, 6559-6565.
17. Goodbourn, S., Burstein, H., and Maniatis, T. (1986). The human β-interferon gene enhancer is under negative control. Cell 45, 601-610.
18. Goodbourn, S., Didcock, L. J., and Randall, R. E. (2000). Interferons: Cell signaling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81, 2341-2364.
19. Gotoh, B., Komatsu, T., Takeuchi, K., and Yokoo, J. (2001). Paramyxovirus accessory proteins as interferon antagonists. Microbiol. Immunol. 45, 787-800.
20. He, et al. (2002). Virology 303, 15-32.
21. Huang, C., Kiyotani, K., Fujii, Y., Fukuhara, N., Kato, A., Nagai, Y., Yoshida, T., and Sakaguchi, T. (2000). Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis. J. Virol. 74, 7834-7841.
22. Iordanov, M. S., Wong, J., Bell, J. C., and Magun, B. E. (2000a). Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs. Mol. Cell. Biol. 21, 61-72.
23. Iordanov, M. S., Paranjape, J. M., Zhou, A., Wong, J., Williams, B. R., Meurs, E. F., Silverman, R. H., and Magun, B. E. (2000b). Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: Involvement of RNase L, protein Kinase R, and alternative pathways. Mol. Cell. Biol. 20, 617-627.
24. Ishii, T., Kwon, H., Hiscott, J., Mosialos, G., and Koromilas, A. E. (2001). Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene 20, 1900-1912.
25. Israel, A. (2000). The IKK complex: An integrator of signals that activate NF-3B? Trends Cell Biol. 10, 129-133.
26. Jacobs, B. L., and Langland, J. O. (1996). When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded RNA. Virology 219, 339-349.
27. Johnston, M. D. (1981). The characteristics required for a Sendai virus preparation to induce high levels of interferon in human lymphoblastoid cells. J. Gen. Virol. 56, 175-184.
28. Juang, Y., Lowther, W., Kellum, M., Au, W. C., Lin, R., Hiscott, J., and Pitha, P. M. (1998). Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95, 9837-9842.
29. Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T., and Nagai, Y. (1997a). The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16, 578-587.
30. Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T., Shioda, T., and Nagai, Y. (1997b). Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J. Virol. 71, 7266-7272.
31. King, P., and Goodbourn, S. (1992). A method for sequence-specific deletion mutagenesis. Nucleic Acids Res. 20, 1039-1044.
32. King, P., and Goodbourn, S. (1994). The β-interferon promoter responds to priming through multiple independent regulatory elements. J. Biol. Chem. 269, 30609-30615.
33. King, P., and Goodbourn, S. (1998). STAT1 is inactivated by a caspase. J. Biol. Chem. 273, 8699-8704.
34. Kumar, A., Yang, Y. L., Flati, V., Der, S., Kadereit, S., Deb, A., Haque, J., Reis, L., Weissmann, C., and Williams, B. R. (1997). Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NF-kappaB. EMBO J. 16, 406-416.
35. Lenardo, M. J., Fan, C.-M., Maniatis, T., and Baltimore, D. (1989). The involvement of NF-κB in β-interferon gene regulation reveals its role as a widely inducible mediator of signal transduction. Cell 57, 287-294.
36. Lin, R., Heylbroeck, C., Pitha, P. M., and Hiscott, J. (1998). Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18, 2986-2996.
37. Lin, G. Y., Paterson, R. G., and Lamb, R. A. (1997). The RNA binding region of the paramyxovirus SV5 V and P proteins. Virology 238, 460-469.
38. Marcus, P. I. (1983). Interferon induction by viruses: One molecule of dsRNA as the threshold for interferon induction. Interferon 5, 115-180.
39. Masson, N., Ellis, M., Goodbourn, S., and Lee, K. A. W. (1992). Cyclic-AMP response element-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter. Mol. Cell. Biol. 12, 1096-1102.
40. Mellits, K. H., Hay, R. T., and Goodbourn, S. (1993). Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21, 5059-5066.
41. Merika, M., and Thanos, D. (2001). Enhanceosomes. Curr. Opin. Genet. Dev. 11, 205-208.
42. Mrkic, B., Odermatt, B., Klein, M. A., Billeter, M. A., Pavlovic, J., and Cattaneo, R. (2000). Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J. Virol. 74, 1364-1372.
43. Naniche, D., Yeh, A., Eto, D., Manchester, M., Friedman, R. M., and Oldstone, M. B. (2000). Evasion of host defenses by measles virus: Wild-type measles virus infection interferes with induction of alpha/beta interferon production. J. Virol. 74, 7478-7484.
44. Nishio, M., Tsurudome, M., Ito, M., Kawano, M., Komada, H., and Ito, Y. (2001). High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: Cysteine-rich V-specific domain is required for high resistance to the interferons. J. Virol. 75, 9165-9176.
45. Parisien, J. P., Lau, J. F., and Horvath, C. M. (2002). STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76, 6435-6441.
46. Parisien, J. P., Lau, J. F., Rodriguez, J. J., Sullivan, B. M., Moscona, A., Parks, G. D., Lamb, R. A., and Horvath, C. M. (2001). The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283, 230-239.
47. Paterson, R. G., Leser, G. P., Shaughnessy, M. A., and Lamb, R. A. (1995). The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology 208, 121-131.
48. Patterson, J. B., Thomas, D., Lewicki, H., Billeter, M. A., and Oldstone, M. B. (2000). V and C proteins of measles virus function as virulence factors in vivo. Virology 267, 80-89.
49. Pellegrini, S., John, J., Shearer, M., Kerr, I. M., and Stark, G. R. (1989). Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9, 4605-4612.
50. Randall, R. E., and Bermingham, A. (1996). NP:P and NP:V interactions of the paramyxovirus simian virus 5 examined using a novel protein: Protein capture assay. Virology 224, 121-129.
51. Randall, R. E., Young, D. F., Goswami, K. K. A., and Russell, W. C. (1987). Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J. Gen. Virol. 68, 2769-2780.
52. Rhee, Y., Gurel, F., Gafni, Y., Dingwall, C., and Citovsky, V. (2000). A genetic system for detection of protein nuclear import and export. Nat. Biotechniques 18, 433-437.
53. Ronco, L. V., Karpova, A. Y., Vidal, M., and Howley, P. M. (1998). Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12, 2061-2072.
54. Sato, M., Tanaka, N., Hata, N., Oda, E., and Taniguchi, T. (1998). Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett. 425, 112-116.
55. Schafer, S. L., Lin, R., Moore, P. A., Hiscott, J., and Pitha, P. M. (1998). Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273, 2714-2720.
56. Schneider, H., Kaelin, K., and Billeter, M. A. (1997). Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 227, 314-322.
57. Servant, M. J., ten Oever, B., LePage, C., Conti, L., Gessani, S., Julkunen, I., Lin, R., and Hiscott, J. (2001). Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J. Biol. Chem. 276, 355-363.
58. Smith, E. J., Marie, I., Prakash, A., Garcia-Sastre, A., and Levy, D. E. (2001). IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by vaccinia virus E3L protein. J Biol. Chem. 276, 8951-8957.
59. Talon, J., Horvath, C. M., Polley, R., Basler, C. F., Muster, T., Palese, P., and Garcia-Sastre, A. (2000). Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74, 7989-7996.
60. Taniguchi, T., Ogasawara, K., Takaoka, A., and Tanaka, N. (2001). Irf family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655.
61. tenOever, B.R., Servant, M. J., Grandvaux, N., Lin, R., and Hiscott, J. (2002). Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J. Virol. 76, 3659-3669.
62. Tober, C., Seufert, M., Schneider, H., Billeter, M. A., Johnston, I. C., Niewiesk, S., ter Meulen, V., and Schneider-Schaulies, S. (1998). Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J. Virol. 72, 8124-8132.
63. Valsamakis, A., Schneider, H., Auwaerter, P. G., Kaneshima, H., Billeter, M. A., and Griffin, D. E. (1998). Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72, 7754-7761.
64. Visvanathan, K. V., and Goodbourn, S. (1989). Double-stranded RNA activates binding of NF-κB to an inducible element in the human β-interferon promoter. EMBO J. 8, 1129-1138.
65. von Magnus, P. (1951a). Propagation of the PR8 strain of influenza virus in chick embryos 2: The formation of "incomplete" virus following the inoculation of large doses of seed virus. Acta Path. Microbiol. Scand. 28, 278-293.
66. von Magnus, P. (1951b). Propagation of the PR8 strain of influenza virus in chick embryos 3: Properties of incomplete virus produced in serial passages of undiluted virus. Acta Path. Microbiol. Scand. 29, 157-181.
67. Wang, X., Li, M., Zheng, H., Muster, T., Palese, P., Beg, A. A., and Garcia-Sastre, A. (2000). Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74, 11566-11573.
68. Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., and Maniatis, T. (1998). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell 1, 507-518.
69. Weaver, B. K., Kumar, K. P., and Reich, N. C. (1998). Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18, 1359-1368.
70. Williams, B. R. G. (2001). Signal integration via PKR. Science's STKE www.stke.org/cg/content/full/OC_sgtrans;2001/89/re2.
71. Yang, Y.-L., Reis, L. F. L., Pavlovic, J., Aguzzi, A., Schafer, R., Kumar, A., Williams, B. R. G., Aguet, M., and Weissmann, C. (1995). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase, PKR. EMBO J. 14, 6095-6106.
72. Yoneyama, M., Suhara, W., Fukuhara, Y., Sato, M., Ozato, K., and Fujita, T. (1996). Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. (Tokyo) 120, 160-169.
73. Yoneyama, M., Suhara, W., Fukuhara, Y., Fukuda, M., Nishida, E., and Fujita, T. (1998). Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087-1095.
74. Young, D. F., Chatziandreou, N., He., B., Didcock, L., Goodbourn, S., Lamb, R. A., and Randall, R. E. (2001). A single amino acid substitution in the V protein of SV5 differentiates its ability to block IFN signaling in human and murine cells. J. Virol. 75, 3363-3370.
75. Young, D. F., Didcock, L., Goodbourn, S., and Randall, R. E. (2000). Paramyxoviridae utilise distinct virus-specific mechanisms to circumvent the interferon response. Virology 269, 383-390.
76. Zamanian-Daryoush, M., Mogensen, T. H., DiDonato, J. A., and Williams, B. R. (2000). NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol. Cell. Biol. 20, 1278-1290.